StockData
Immix Biopharma, Inc. logo

Immix Biopharma, Inc. (IMMX) stock

IMMXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/30
$7.48−0.36 (-4.59%)

Close on Nov 16, 2026Market cap $535.11MP/E –Yield –

Immix Biopharma EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

No ev/ebitda figures for Immix Biopharma

Immix Biopharma has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Immix Biopharma figures

See a number that looks wrong?